| Potential role for ESAT6 in dissemination of M. tuberculosis via human lung epithelial cells AG Kinhikar, I Verma, D Chandra, KK Singh, K Weldingh, P Andersen, ... Molecular microbiology 75 (1), 92-106, 2010 | 157 | 2010 |
| Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis S Sharma, I Verma, GK Khuller Antimicrobial agents and chemotherapy 45 (2), 639-640, 2001 | 122 | 2001 |
| Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study S Sharma, I Verma, GK Khuller European Respiratory Journal 16 (1), 112-117, 2000 | 115 | 2000 |
| Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy A Kalita, I Verma, GK Khuller The Journal of infectious diseases 190 (8), 1476-1480, 2004 | 111 | 2004 |
| Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity SB Sable, M Kalra, I Verma, GK Khuller Clinical immunology 122 (3), 239-251, 2007 | 67 | 2007 |
| COVID-19 associated variations in liver function parameters: a retrospective study RK Saini, N Saini, S Ram, SL Soni, V Suri, P Malhotra, J Kaur, I Verma, ... Postgraduate Medical Journal 98 (1156), 91-97, 2022 | 65 | 2022 |
| Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection D Gupta, S Kumar, AN Aggarwal, I Verma, R Agarwal Sarcoidosis Vasc Diffuse Lung Dis 28 (2), 95-101, 2011 | 65 | 2011 |
| Cholesterol-sensor initiates M. tuberculosis entry into human macrophages D Kaul, PK Anand, I Verma Molecular and cellular biochemistry 258, 219-222, 2004 | 63 | 2004 |
| Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis PK Giri, SB Sable, I Verma, GK Khuller FEMS Immunology & Medical Microbiology 45 (1), 87-93, 2005 | 62 | 2005 |
| Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge … PK Giri, I Verma, GK Khuller FEMS Immunology & Medical Microbiology 47 (2), 233-241, 2006 | 61 | 2006 |
| Biochemical interaction of human neutrophil peptide-1 with Mycobacterium tuberculosis H37Ra S Sharma, I Verma, GK Khuller Archives of Microbiology 171, 338-342, 1999 | 61 | 1999 |
| Immunobiological properties of a 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra RK Sinha, I Verma, GK Khuller Vaccine 15 (6-7), 689-699, 1997 | 58 | 1997 |
| Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice PK Giri, I Verma, GK Khuller Journal of Infection 53 (5), 350-356, 2006 | 57 | 2006 |
| Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis SB Sable, I Verma, GK Khuller Vaccine 23 (32), 4175-4184, 2005 | 56 | 2005 |
| Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1 R Sharma, R Raghav, K Priyanka, P Rishi, S Sharma, S Srivastava, ... Scientific reports 9 (1), 7866, 2019 | 53 | 2019 |
| Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides of Mycobacterium tuberculosis in Human Models … SB Sable, R Kumar, M Kalra, I Verma, GK Khuller, K Dobos, JT Belisle Infection and immunity 73 (6), 3547-3558, 2005 | 51 | 2005 |
| Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population R Saxena, YK Chawla, I Verma, J Kaur The Indian journal of medical research 139 (5), 737, 2014 | 49 | 2014 |
| Effect of IL-12B, IL-2, TGF-β1, and IL-4 polymorphism and expression on hepatitis B progression R Saxena, YK Chawla, I Verma, J Kaur Journal of Interferon & Cytokine Research 34 (2), 117-128, 2014 | 48 | 2014 |
| Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice M Kalra, A Grover, N Mehta, J Singh, J Kaur, SB Sable, D Behera, ... Clinical Immunology 125 (2), 173-183, 2007 | 48 | 2007 |
| Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India M Vinish, S Prabhakar, M Khullar, I Verma, A Anand Journal of Neurology, Neurosurgery & Psychiatry 81 (2), 166-170, 2010 | 46 | 2010 |
Suman LaalNew York University Langone Medical Center; VA Medical CenterAdresse e-mail validée de nyumc.org
